A previous study reported that surface expression of PD-L1 and phosphorylation of STAT1 in pancreatic cancer cell lines was elicited by treatment with conventional chemotherapeutic drugs including 5FU, gemcitabine, and paclitaxel, although the correlation with phenotypic drug response was not clear (44). This evidence concerns the gene CD274 and familial pancreatic carcinoma.